Skip to main content

Synonyms

Alti-Haloperidol; Apo-Haloperidol; Haldolâ„¢; Novo-Peridol; Peridol; Pms-Haloperidol; Ratio-Haloperidol

Definition

The brand name of haloperidol in the United States is Haldol. Canadian brand names include Alti-Haloperidol, Apo-Haloperidol, Novo-Peridol, Peridol, Pms-Haloperidol, and Ratio-Haloperidol. It comes in three forms: a pill, an intramuscular injection, and a longacting depot decanoate form and is manufactured by Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Indications

The oral and immediate-release injection forms of haloperidol are FDA-approved for the treatment of schizophrenia as well as for tics and vocal utterances associated with Tourette’s disorder (Janssen, 2005). These forms are also used as second-line treatment to manage hyperactivity in the pediatric population as well as for severe behavior problems, particularly combativeness, explosiveness, and hyperexcitability (Stahl, 2009). The long-acting depot intramuscular decanoate form of haloperidol is approved...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,799.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References and Readings

  • Anderson, L. T., Campbell, M., et al. (1984). Haloperidol in the treatment of infantile autism: Effects on learning and behavioral symptoms. The American Journal of Psychiatry, 141(10), 1195–1202.

    PubMed  Google Scholar 

  • Anderson, L. T., Campbell, M., et al. (1989). The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. Journal of Autism and Developmental Disorders, 19(2), 227–239.

    PubMed  Google Scholar 

  • Campbell, M., Anderson, L. T., et al. (1978). A comparison of haloperidol and behavior therapy and their interaction in autistic children. Journal of the American Academy of Child Psychiatry, 17(4), 640–655.

    PubMed  Google Scholar 

  • Cohen, I. L., Campbell, M., et al. (1980). Behavioral effects of haloperidol in young autistic children. An objective analysis using a within-subjects reversal design. Journal of the American Academy of Child Psychiatry, 19(4), 665–677.

    PubMed  Google Scholar 

  • Faretra, G., Dooher, L., et al. (1970). Comparison of haloperidol and fluphenazine in disturbed children. The American Journal of Psychiatry, 126(11), 1670–1673.

    PubMed  Google Scholar 

  • Janssen-Cilag Pty Limited. (2005). Haldol product information. Retrieved from http://www.janssen.com.au/files/Products/Haldol_PI.pdf

  • Malone, R. P., & Waheed, A. (2009). The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism. Drugs, 69(5), 535–548.

    PubMed  Google Scholar 

  • Miral, S., Gencer, O., et al. (2008). Risperidone versus haloperidol in children and adolescents with AD: A randomized, controlled, double-blind trial. European Child & Adolescent Psychiatry, 17(1), 1–8.

    Google Scholar 

  • Naruse, H., Nagahata, M., et al. (1982). A multi-center double-blind trial of pimozide (Orap), haloperidol and placebo in children with behavioral disorders, using crossover design. Acta Paedopsychiatrica, 48(4), 173–184.

    PubMed  Google Scholar 

  • Perry, R., Campbell, M., et al. (1989). Long-term efficacy of haloperidol in autistic children: Continuous versus discontinuous drug administration. Journal of the American Academy of Child and Adolescent Psychiatry, 28(1), 87–92.

    PubMed  Google Scholar 

  • Remington, G., Sloman, L., et al. (2001). Clomipramine versus haloperidol in the treatment of autistic disorder: A double-blind, placebo-controlled, crossover study. Journal of Clinical Psychopharmacology, 21(4), 440–444.

    PubMed  Google Scholar 

  • Stahl, S. M. (2008). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (3rd ed., pp. 328–342). New York: Cambridge University Press.

    Google Scholar 

  • Stahl, S. M. (2009). Stahl’s essential psychopharmacology: The prescriber’s guide (3rd ed., pp. 237–242). New Delhi, India: Cambridge University Press.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carolyn A. Doyle .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this entry

Cite this entry

Doyle, C.A., McDougle, C.J. (2013). Haloperidol. In: Volkmar, F.R. (eds) Encyclopedia of Autism Spectrum Disorders. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1698-3_826

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1698-3_826

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1697-6

  • Online ISBN: 978-1-4419-1698-3

  • eBook Packages: Behavioral Science

Publish with us

Policies and ethics